Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236510 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
Patients with 1-3N+ and young age, Grade III, or ER-negative disease have high LRR risks approximating 15% to 20% despite BCS, whole-breast RT and systemic therapy. These patients may benefit with more comprehensive RT volume encompassing the regional nodes.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pauline T. M.D., C.M., F.R.C.P.C., Stuart O. B.Sc., Hosam A. M.D., F.R.C.P.C., Elaine S. M.D., F.R.C.P.C., Caroline H. B.A., Abraham S. M.D., F.R.C.P.C., Ivo A. M.D., F.R.C.P.C.,